Oncternal Therapeutics Announces Presentation of Two Abstracts at ASCO 2021 Virtual Meeting

SAN DIEGO, April 28, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the presentation of two abstracts at the American Society of Clinical Oncology (ASCO) 2021 Annual Meeting being held virtually from June 4-8, 2021.

Click here to view original post